Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-17

Clinical Trial Update: Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated fluconazole prophylaxis to prevent candidiasis in extremely low birthweight infants (less than 750 grams).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

Sponsor: Daniel Benjamin | Conditions: Candidiasis | Phase 3 | Status: COMPLETED | Results posted: 2014-07-17